Loading the section…
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | 31/12/2025 | 31/12/2024 |
|---|---|---|
| Revenue | 120M | 109M |
| Cost of revenue | 87M | 70M |
| Research and development | 7M | 4M |
| Selling, general and administrative | 23M | 29M |
| Operating expenses | 86M | 41M |
| Operating income | −53M | −2M |
| Pre-tax income | −53M | −5M |
| Income tax | 12,000 | −164,000 |
| Net income | −53M | −5M |
| Earnings per share | −1.27 | −0.14 |
| Earnings per share, diluted | −1.27 | −0.14 |
| Weighted average shares | 42M | 36M |
| Weighted average shares, diluted | 42M | 36M |
| Metric | 31/03/2026 | 31/12/2025 | 30/09/2025 | 30/06/2025 | 31/03/2025 | 31/12/2024 | 30/09/2024 | 30/06/2024 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 5M | 7M | 7M | 7M | 6M | 14M | 57M | 37M |
| Receivables | 16M | 15M | 14M |
| Metric | 31/12/2025 | 31/12/2024 |
|---|---|---|
| Operating cash flow | −3M | 10M |
| Depreciation and amortisation | 12M | 9M |
| Share-based compensation | 3M | 3M |
| Capital expenditure | 9M | 85M |
| Investing cash flow | −8M | −85M |
| Financing cash flow | 4M |
Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator
| 16M |
| 15M |
| 15M |
| 17M |
| 16M |
| Inventory | 20M | 16M | 16M | 21M | 22M | 19M | 18M | 23M |
| Current assets | 46M | 44M | 44M | 51M | 48M | 52M | 87M | 71M |
| Total assets | 232M | 231M | 278M | 285M | 284M | 284M | 280M | 249M |
| Current liabilities | 45M | 42M | 40M | 46M | 43M | 45M | 30M | 27M |
| Total liabilities | 64M | 63M | 61M | 68M | 65M | 67M | 62M | 59M |
| Equity | 168M | 168M | 217M | 217M | 218M | 217M | 218M | 190M |
| Shares outstanding | 43M | 43M | 43M | 43M | 42M | 42M | 42M | 36M |
| Shares issued | 47M | 47M | 47M | 47M | 47M | 47M | 47M | 41M |
| Treasury shares | 5M | 5M | 5M | 5M | 5M | 5M | 5M | 5M |
| 43M |